GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bacil Pharma Ltd (BOM:524516) » Definitions » Other Net Income (Loss)

Bacil Pharma (BOM:524516) Other Net Income (Loss) : ₹-0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 1994. Start your Free Trial

What is Bacil Pharma Other Net Income (Loss)?

Bacil Pharma's Other Net Income (Loss) for the three months ended in Mar. 2025 was ₹0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-0.00 Mil.

Bacil Pharma's annual Other Net Income (Loss) stayed the same from Mar. 2023 (₹0.00 Mil) to Mar. 2024 (₹0.00 Mil) but then declined from Mar. 2024 (₹0.00 Mil) to Mar. 2025 (₹-0.00 Mil).


Bacil Pharma Other Net Income (Loss) Historical Data

The historical data trend for Bacil Pharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bacil Pharma Other Net Income (Loss) Chart

Bacil Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bacil Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bacil Pharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bacil Pharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Bacil Pharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Bacil Pharma Business Description

Traded in Other Exchanges
N/A
Address
Sir P. M. Road, No. 71, Laxmi Building, 4th Floor, Fort, Mumbai, MH, IND, 400 001
Bacil Pharma Ltd is an Indian-based pharmaceutical company operating in a single segment. It is engaged in the manufacturing of pharmaceuticals, medicinal chemicals, and botanical products. The company manufactures, exports, supplies, and retail Anti Anxiety Medicine, Antihistamines, Chemical Compound, Drugs and Herbal Tablets, and Capsules.

Bacil Pharma Headlines

No Headlines